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ABSTRACT
Airway epithelial cells are susceptible to infection with seasonal influenza A viruses (IAV), resulting in productive virus replica-
tion and release. Macrophages (M) are also permissive to IAV infection; however, virus replication is abortive. Currently, it is
unclear how productive infection of M is impaired or the extent to which seasonal IAV replicate inM. Herein, we compared
mouseM and epithelial cells for their ability to support genomic replication and transcription, synthesis of viral proteins, as-
sembly of virions, and release of infectious progeny following exposure to genetically defined IAV.We confirm that seasonal IAV
differ in their ability to utilize cell surface receptors for infectious entry and that this represents one level of virus restriction.
Following virus entry, we demonstrate synthesis of all eight segments of genomic viral RNA (vRNA) andmRNA, as well as seven
distinct IAV proteins, in IAV-infected mouseM. Although newly synthesized hemagglutinin (HA) and neuraminidase (NA)
glycoproteins are incorporated into the plasmamembrane and expressed at the cell surface, electronmicroscopy confirmed that
virus assembly was defective in IAV-infectedM, defining a second level of restriction late in the virus life cycle.
IMPORTANCE
Seasonal influenza A viruses (IAV) and highly pathogenic avian influenza viruses (HPAI) infect macrophages, but only HPAI
replicate productively in these cells. Herein, we demonstrate that impaired virus uptake into macrophages represents one level of
restriction limiting infection by seasonal IAV. Following uptake, seasonal IAV do not complete productive replication in macro-
phages, representing a second level of restriction. Using murine macrophages, we demonstrate that productive infection is
blocked late in the virus life cycle, such that virus assembly is defective and newly synthesized virions are not released. These
studies represent an important step toward identifying host-encoded factors that block replication of seasonal IAV, but not
HPAI, in macrophages.
In humans, infection with seasonal influenza A viruses (IAV) isgenerally restricted to the respiratory tract. IAV infection of air-
way epithelial cells (AEC) is initiated following recognition of cell
surface sialic acid (SIA) by the viral hemagglutinin (HA) glyco-
protein (reviewed in reference 1). In addition to HA-SIA binding,
it is likely that particular membrane-associated glycoproteins
and/or glycolipids facilitate virus entry into AEC; however, the
identity of such an entry receptor(s) is currently unknown. IAV
infection of AEC results in productive virus replication, charac-
terized by synthesis of viral RNA (vRNA) andmRNA, production
of viral proteins, virion assembly, and budding of viral progeny
from the surfaces of infected cells. Productive infection of AEC
results in amplification of IAV in the airways, promoting virus
dissemination and disease.
In addition toAEC,macrophages (M) are one of the first cells
in the respiratory tract to detect and respond to IAV. As for AEC,
binding of the IAV HA to SIA concentrates virus at the M cell
surface to promote interactions with other receptors that facilitate
virus entry.While IAV infection ofAEC results in productive virus
replication, infection of M with seasonal IAV is generally con-
sidered to be abortive (reviewed in reference 2). These findings
indicate that M and AEC respond very differently to infection
with seasonal IAV and suggest an important role for M in lim-
iting infection and disease. Consistent with this, depletion of air-
way M has been associated with enhanced virus replication and
disease in mice (3), ferrets (4), and pigs (5) following infection
with seasonal IAV strains.
As M can limit the severity of IAV-induced disease, virus
strains that evade or exploitM defenses are likely to cause severe
disease. Our recent studies identified the M mannose receptor
(MMR) and M galactose-type lectin-1 (MGL1) as attachment
and entry receptors for IAV. Glycans expressed on the HA and
neuraminidase (NA) surface glycoproteins of IAV are recognized
by MMR and/or MGL1, promoting infectious entry into mouse
M (6–8). However, the mouse-virulent A/Puerto Rico/9/34
(PR8; H1N1 subtype) strain is poorly glycosylated and not recog-
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nized efficiently by either receptor, consistent with its limited ca-
pacity to infect mouse M in vitro (6, 7, 9).
At least three hypotheses have been proposed to account for
the restriction of IAV replication in M. First, differences be-
tween seasonal IAV in their ability to utilize cell surface receptors
for viral entry suggest that impaired virus uptake into Mmight
represent one level at which virus replication is restricted. How-
ever, at least some seasonal IAV strains infect M efficiently, re-
sulting in intracellular synthesis of viral nucleoprotein (NP)
and/or HA proteins (6, 7, 10), yet no infectious viral progeny are
released. Thus, a block in virus assembly and/or budding may
represent a second level of replication restriction in M. Third, a
recent study proposed that following virus internalization, a sub-
sequent block(s) early in the virus life cycle restricted efficient
nuclear entry and therefore, viral transcription and translation
and ultimately, replication of seasonal IAV (11). To gain further
insight regarding the extent to which viral replication proceeds
and the mechanism(s) by which productive replication is blocked
in M, the present study has defined vRNA and mRNA synthesis
for each gene segment, production of individual viral proteins,
and assessment of virus assembly and release inM, using epithe-
lial cells as control cells that support productive replication of
seasonal IAV. These studies confirm that impaired virus uptake
into M represents one level of restriction. While uptake and
nuclear entry of viral RNPs can occur efficiently in IAV-infected
M, additional restrictions late in the virus life cycle prevented
virus assembly, and therefore productive replication, in M.
MATERIALS AND METHODS
Cell lines and primary macrophages. Madin-Darby canine kidney
(MDCK) cells (American Type Culture Collection [ATCC], Manassas,
VA) were cultured in RPMI 1640 medium (Gibco-BRL, NY) supple-
mented with 10% (vol/vol) fetal calf serum (JRH Biosciences, KS), 4 mM
L-glutamine, 100 IU of penicillin, 10g of streptomycin/ml, nonessential
amino acids (Gibco-BRL), and 50 M -mercaptoethanol. LA-4 mouse
lung epithelial cells and the RAW264.7 M cell line (ATCC) were cul-
tured in Kaign’s modification of Ham’s F-12 medium (Gibco-BRL) and
Dulbecco modified Eagle medium (DMEM) (Gibco-BRL), respectively,
supplemented as described above. MDCK cells (2.5  104 cells/well),
LA-4 cells (5 104 cells/well), and RAW264.7 cells (6.25 104 cells/well)
were seeded into eight-well glass chamber slides (LabTek, Nunc, USA)
and incubated overnight to form a confluent monolayer prior to use in
virus infection assays.
C57BL/6 mice were bred and housed in specific-pathogen-free condi-
tions at the Department of Microbiology and Immunology, University of
Melbourne. Mice 6 to 10 weeks of age were used in experiments con-
ducted according to the guidelines of theUniversity ofMelbourneAnimal
Ethics Committee. Resident peritoneal exudate cell (PEC)M and bron-
choalveolar lavage (BAL) fluid M were obtained from C57BL/6 mice as
previously described (7). M (2.5  105 cells/well) were seeded into
eight-well glass chamber slides in RPMI 1640 medium supplemented as
described above and incubated for 4 h at 37°C, and the adherent M
population was washed to remove nonadherent cells before overnight
incubation at 37°C.
Viruses. Reassortant IAVwere generated by eight-plasmid reverse ge-
netics as described previously (12). The viruses used were 7:1 reassortants
consisting of the A/PR8/34 (PR8, H1N1) backbone with the HA from
A/Brazil/11/78 (RG-Braz-HA) or all eight genes fromPR8 (RG-PR8-HA).
The rescued viruses were recovered after 3 days and amplified in the al-
lantoic cavities of 10-day-old embryonated eggs and titrated on MDCK
cells by standard procedures (13). Viruses were purified by rate zonal
sedimentation on 25 to 80% (wt/vol) sucrose gradients as described pre-
viously (13).
Virus infection assays. M and epithelial cells were infected with
IAV, and the percentage of IAV-infected cells was determined as described
previously (8, 14). Unless stated otherwise, the cells were incubated with
106 PFU of IAV (representing a multiplicity of infection [MOI] of 5 PFU/
cell) in serum-freemedium for 1 h at 37°C. Virus inoculumwas removed,
and the cells were washed and incubated for a further 1 to 7 h at 37°C in
serum-free medium. IAV-infected cells were stained using monoclonal
antibody (MAb) MP3.10g2.1C7 (WHO Collaborating Centre for Refer-
ence and Research on Influenza, Melbourne, Australia), specific for the
IAV nucleoprotein (NP), followed by fluorescein isothiocyanate (FITC)-
conjugated goat anti-mouse Ig (Millipore, MA). The percentage of virus-
infected cells was determined by costaining with 4=,6-diamidino-2-phe-
nylindole (DAPI) or propidium iodide (PI). A minimum of 200 cells was
counted for each sample. Images were acquired with a Zeiss LSM700
confocal microscope (Zeiss, Germany) andmanaged using Adobe Photo-
shop software.
In some experiments, cells were pretreated with (i) 5 mg/ml of asia-
lofetuin (ASF) (Sigma-Aldrich) or (ii) 10 mg/ml of mannan (Sigma-Al-
drich) in serum-free medium for 30 min at 37°C to block C-type lectin
receptors (CLR) prior to the addition of virus inoculum. In other exper-
iments, virus inoculum was added in the presence of a 10 nM concentra-
tion of the NA inhibitor zanamivir (4-guanidino-2,3-dehydro-N-acetyl-
neuraminic acid; purchased from GlaxoSmithKline, Australia).
Virus binding assays. The ability of IAV to bind to cells was deter-
mined by flow cytometric analysis. Briefly, cells were detached by gentle
scraping in phosphate-buffered saline (PBS) with 1 mM EDTA and incu-
bated with 10g/ml of purified RG-Braz-HA or RG-PR8-HA virus at 4°C
for 30 min in Tris-buffered saline (TBS) containing 5 mM calcium and 1
mg/ml bovine serum albumin (BSA) (Sigma-Aldrich). Bound virus was
detected using rabbit polyclonal antisera raised against N1 neuraminidase
(NA) (R301, obtained from theWHOCollaborating Centre for Reference
and Research on Influenza, Melbourne, Australia) in conjunction with
goat anti-rabbit Ig–FITC conjugate (Millipore). Note that at 10 g/ml,
purified RG-Braz-HA or RG-PR8-HA viruses showed equivalent hemag-
glutinating activity using 1% turkey erythrocytes.
Virus growth assays. To determine whether infection resulted in am-
plification and release of infectious virus from target cells, we first per-
formed experiments to examine release of infectious virus following a
single cycle of virus replication (i.e., in the absence of exogenous trypsin).
Cell monolayers in chamber slides were infected with 106 PFU/well (MOI
of 5) of virus, as described above. Cell supernatants were collected at 2 and
24 h postinfection, and incubated with tosylsulfonyl phenylalanyl chlo-
romethyl ketone (TPCK)-treated trypsin (4 g/ml; Sigma, USA) for 30
min at 37°C to facilitate cleavage of viral hemagglutinin (1), before the
titers of infectious virus were determined by standard plaque assay on
MDCK cells.
In experiments to examine virus release following multiple cycles of
virus replication, cell monolayers were infected with virus at an MOI of
0.01 and washed and cultured in serum-free medium supplemented with
1 g/ml TPCK-treated trypsin. Cell supernatants were removed at 2, 24,
and 48 h, and titers of infectious virus were determined by plaque assay on
MDCK cells.
qRT-PCR for detection of host antiviral factors in IAV-infected
cells. Reverse transcriptase quantitative PCR (qRT-PCR) was used to de-
termine expression of the following host antiviral genes in mock-infected
and IAV-infected cells: interferon (IFN)-induced protein with tetratrico-
peptide repeats 1 (IFIT1; TaqMan identifier [ID] Mm00515153_m1),
IFN-induced protein with tetratricopeptide repeats 3 (IFIT3; TaqMan ID
Mm01704846_s1), eukaryotic translation initiation factor 2 alpha kinase
2 (Eif2ak; TaqMan ID Mm01235643_m1), IFN induced with helicase C
domain I (Ifih1 [Mda5]; TaqMan ID Mm00459183_m1), Mxyovirus re-
sistance 1 (Mx1; TaqMan ID Mm00487796_m1), and IFN-stimulated
protein 20 (Isg20; TaqMan IDMm00469585_m1). Briefly, cell monolay-
ers were infected as described above. At 2 or 6 h postinfection, total RNA
was extracted from cells using the RNeasy minikit (Qiagen, USA) accord-
Londrigan et al.
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ing to the manufacturer’s instructions, then treated with DNase (TURBO
DNase kit; Life Technologies, Australia) to remove contaminating DNA,
and stored at70°C. Five hundred nanograms of total RNA was reverse
transcribed into cDNA using the Superscript VILO cDNA synthesis kit
(Life Technologies). qRT-PCR was performed using 2 ng of cDNA, Taq-
Man gene expression assays (Life Technologies), and TaqMan Fast Ad-
vanced mastermix on the StepOnePlus real-time PCR machine (Life
Technologies). The threshold cycles (CTs) of gene targets determined by
qRT-PCR were normalized to the geometric means of the CTs of three
endogenous control genes, phosphoglycerate kinase 1 (Pgk1; TaqMan ID
Mm00435617_m1), TATA box binding protein (Tbp; TaqMan ID
Mm00446973_m1), and hypoxanthine guanine phosphoribosyltrans-
ferase (Hprt; TaqMan ID Mm00446968_m1). The relative levels of ex-
pression for each sample were determined using the 2CT method (15).
qRT-PCR for influenza virus mRNA and vRNA. The levels of viral
RNA (vRNA) and mRNA for each IAV gene in virus-infected cells were
determined by qRT-PCR. Briefly, cell monolayers were infected, and then
RNAextraction andDNase treatmentwere performed as described above.
The levels of vRNA and mRNA for the matrix (M), NP, HA, NA, poly-
merase acidic protein (PA), polymerase B subunit 1 (PB1), PB2, and non-
structural protein (NS) genes were determined via qRT-PCR using SYBR
green-based chemistry, as described previously (16). Briefly, cDNA was
synthesized using the Omniscript reverse transcriptase kit (Qiagen, USA)
according to the manufacturer’s instructions with oligo(dT)s (Roche,
Australia) for mRNA or Uni12 primer (17) for vRNA. cDNA was then
used for the real-time PCRwith the SensiMIX SYBRHi-ROX kit (Bioline,
Australia) according to the manufacturer’s instructions, using a Strat-
agene Mx3005 instrument in conjunction with MxPro software (Agilent
Technologies, CA, USA). Specific primer sequences are available upon
request. vRNA andmRNA copy numbers were calculated by generating a
standard curve using serial dilutions of plasmid containing DNA for each
IAV gene.
Western blotting for IAV proteins. Confluent cell monolayers were
infected in chamber slides as described above. Whole virus-cell lysates
were prepared at 2 and 16 h postinfection using a buffer comprising 50
mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.5% (vol/vol) Triton X-100, 1
mMCaCl2, 1mMMgCl2, and broad-spectrumprotease inhibitor cocktail
(Roche, Mannheim, Germany). Samples were heated to 90°C for 5 min
before separation by SDS-PAGE under reducing conditions using 10 to
12.5% gels, followed by transfer to polyvinylidene difluoride (PVDF)
membranes (Millipore) in Tris-glycine transfer buffer (25 mM Tris con-
taining 192 mM glycine and 10% [vol/vol] methanol; pH 8.3). To detect
IAV proteins, membranes were blocked in PBS containing 5% (wt/vol)
BSA and 0.1% (vol/vol) Tween 20 (Sigma). All subsequent wash and an-
tibody binding steps were performed in PBS containing 0.05% (vol/vol)
Tween 20. Cellular -actin (approximately 43 kDa) was monitored to
ensure equivalent protein loading of all samples using a mouse monoclo-
nal antibody to -actin (clone sc-47778; Santa Cruz, CA, USA) in con-
junction with chicken anti-mouse Ig–Alexa Fluor 488 conjugate (Life
Technologies, OR, USA). IAV nonstructural protein 1 (NS1; approxi-
mately 26 kDa) and nonstructural protein 2 (NS2; approximately 14 kDa)
were detected using rabbit polyclonal antibodies specific for each protein
(PA5-32243 and PA5-32234, respectively, purchased fromThermo Scien-
tific, Rockford, IL, USA) in conjunction with donkey anti-rabbit Ig–Alexa
Fluor 568 conjugate (Life Technologies). IAV matrix 1 protein (M1; ap-
proximately 27 kDa) and matrix 2 protein (M2 approximately 11 kDa)
were detected using mouse monoclonal antibodies to M1 (clone GA2B;
Serotec) and M2 (clone 14C2; Abcam, Cambridge, United Kingdom) in
conjunction with chicken anti-mouse Ig–Alexa Fluor 488 conjugate. IAV
NP (approximately 46 kDa) was detected using mouse monoclonal anti-
body to NP (cloneMP3.10g2.1C7;WHOCollaborating Centre for Refer-
ence and Research on Influenza, Melbourne, Australia) in conjunction
with chicken anti-mouse Ig–Alexa Fluor 488 conjugate. Images were ob-
tained using a Pharos FX Plus molecular imager (Bio-Rad) and managed
using Adobe Photoshop software.
Fluorescence-activated cell sorting (FACS) analysis for IAV pro-
teins. Cells were infected with IAV as described above. At 2 h and 8 h
postinfection, infected cells were detached by scraping in PBS containing
1 mM EDTA. IAV HA and NA proteins expressed at the cell surface were
detected using a mouse monoclonal antibody specific for H1 HA (MAb
43, obtained from the WHO Collaborating Centre for Reference and Re-
search on Influenza,Melbourne, Australia) in conjunctionwith goat anti-
mouse Ig–FITC conjugate (Millipore) or rabbit anti-NA polyclonal anti-
sera (R301, obtained from the WHO Collaborating Centre for Reference
and Research on Influenza, Melbourne, Australia) in conjunction with
goat anti-rabbit Ig–FITC conjugate (Millipore), respectively, followed by
flow cytometric analysis.
TEM. To visualize budding complexes on cell surfaces, PEC M or
MDCK cells were infected with 106 PFU (MOI of 5 PFU/cell) of RG-
Braz-HA as described above. At 16 h postinfection, cells were fixed with
2.5% (vol/vol) glutaraldehyde in PBS for 30min on ice.Washed cells were
postfixed in 1% osmium tetroxide (1 h, room temperature) before being
dehydrated in a graded series of ethanol solutions and embedded in
Spurr’s low-viscosity embedding mixture (Electron Microscopy Sciences
[EMS],Hatfield, PA). Sectionswere cutwith anultramicrotome, collected
onto coated copper grids, stainedwith saturated uranyl acetate for 10min,
and then triple lead stained. Sections were viewed using a Philips CM-10
transmission electronmicroscope (TEM) (Philips, TheNetherlands) at 60
kV, and images were obtained using a Quemesa TEM camera (Olympus,
Germany).
Statistical analysis.Graphing and statistical analysis of data were per-
formed using GraphPad Prism (GraphPad Software, San Diego, CA). For
comparison of multiple data sets, one-way analysis of variance (ANOVA)
with Tukey’s multiple comparative analysis was used. For analysis of two
data sets, an unpaired two-tailed Student’s t test was used. A P value of
0.05 was considered statistically significant in both applications.
RESULTS
Infection of mouse M and epithelial cells by genetically de-
fined strains of IAV that differ only inHA gene expression.Gly-
cosylation of IAV HA is a critical factor modulating the ability of
C-type lectin receptors (CLR) to recognize different IAV. Highly
glycosylated strains infect murineMmore efficiently, and infec-
tion is blocked bymultivalent ligands of CLR such asmannan and
asialofetuin (ASF) (6–8). We aimed to generate genetically de-
fined viruses that differed only in their HA gene, such that one
expressed theHA of the highly glycosylatedH1N1 strain A/Brazil/
11/78 (Braz; H1N1, four potential glycosylation sites on the head
of HA) and the other expressed the HA of the H1N1 strain
A/Puerto Rico/8/34 (PR8; H1N1), which lacks glycosylation sites
on the head of HA. While differences in glycosylation will not be
the only features of the viralHA to differ between these strains, our
previous studies reported that we could not rescue virus mutants
expressing the PR8 HA if more than two additional glycosylation
sites had been added (18). Therefore, reverse genetics was used to
engineer IAV expressing seven genes from PR8 with the HA gene
either from Braz (RG-Braz-HA [RG stands for reverse genetics])
or from PR8 (RG-PR8-HA).
We compared the ability of RG-Braz-HA and RG-PR8-HA to
infect MDCK epithelial cells (a standard cell line for propagation
of IAV) and LA-4 epithelial cells (a mouse airway epithelial cell
line), as well as mouse BAL fluid M, PEC M, and the mouse
RAW264.7 M cell line. Images of RG-Braz-HA- and RG-PR8-
HA-infected cells are shown in Fig. 1A. By immunofluorescence,
therewas little evidence of expression of IAVNP in LA-4 epithelial
cells (Fig. 1Ai and Aii, top panels) or PEC M (Fig. 1Ai and Aii,
bottom panels) 2 h after incubation with either strain of IAV.
However, IAVNPwas readily detected in LA-4 epithelial cells by 8
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h postinfection with both RG-Braz-HA and RG-PR8-HA strains
(Fig. 1Ai and Aii, top panels), consistent with detection of newly
synthesized viral antigen in IAV-infected cells. IAV NP was ob-
served only in PEC M infected with RG-Braz-HA, and not RG-
PR8-HA, at 8 h postinfection (Fig. 1Ai and Aii, bottom panels).
Similar results were obtained using MDCK cells, BAL fluid M,
and RAW264.7 cells (data not shown). To determine the percent-
age of IAV-infected cells, PI-positive (PI) cells and fluorescent
NP-positive (NP) cells were counted 7 to 8 h postinfection. RG-
Braz-HA and RG-PR8-HA infected MDCK and LA-4 epithelial
cells to equivalent levels (Fig. 1B), whereas only RG-Braz-HA in-
fected mouse BAL fluid M, PEC M, and the RAW264.7 M
cell line efficiently. Consistent with published data (6–8), infec-
tion of M, but not epithelial cells by IAV, was blocked by mul-
tivalent ligands of CLR (data not shown).
IAV-infected mouse epithelial cells, but not M, support
productive viral infection. Previously published studies report
that infection of mouse M with seasonal IAV results in abortive
infection (7, 10, 11, 19, 20), although one study described produc-
tive replication ofH1N1 IAV inmouse bonemarrow-derivedM
(21). Therefore, we investigated the ability of mouse M to sup-
port productive replication of RG-Braz-HA, a virus strain that
infects all mouse M populations to high levels. Monolayers of
mouse M (PEC M and RAW264.7 M) and epithelial cells
(MDCK cells and LA-4 cells) were incubated with 106 PFU (MOI
of 5 PFU/cell) of RG-Braz-HA for 1 h, washed extensively to re-
move excess virus, and then cultured. At 2 and 24 h postinfection,
supernatants were removed and clarified by centrifugation, and
titers of infectious virus were determined by plaque assay on
MDCK cells. As seen in Fig. 2A, RG-Braz-HA replicated produc-
tively in MDCK cells and LA-4 cells, as titers of infectious virus
increased significantly between 2 h (where residual virus inocu-
lum will be detected) and 24 h (representing virus released from
infected cells). As expected, MDCK cells supported productive
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FIG 1 Differential infection of epithelial cells and mouse M by genetically defined strains of IAV that differ only in HA gene expression. Monolayers of LA-4
epithelial cells (top panels) and PECM (bottom panels) were infected with anMOI of 5 PFU/cell of RG-PR8-HA or RG-Braz-HA for 1 h at 37°C. Excess virus
was removed by washing, and the cells were then fixed at either 2 h or 8 h postinfection and stained by immunofluorescence for expression of newly synthesized
viral NP (green) as described in Materials and Methods. DAPI staining (blue) was performed to visualize cell nuclei. (A) Viral NP cells are visible at 8 h
postinfection in epithelial cells infected with either RG-PR8-HA or RG-Braz-HA and only in M infected with RG-Braz-HA. Magnification,20. (B) Mono-
layers of epithelial cells (MDCK and LA-4) and mouse M (BAL fluid M, PECM, and RAW264.7 cells) were infected with RG-PR8-HA or RG-Braz-HA as
described above and then fixed at 8 h postinfection before staining by immunofluorescence to detect newly synthesized viral NP.Data represent themean percent
infection (	 standard error of themean [SEM] [error bar]) fromno less than four independent fields per chamber and are representative of at least three separate
experiments.
Londrigan et al.
12322 jvi.asm.org December 2015 Volume 89 Number 24Journal of Virology
 o
n
 O
ctober 28, 2018 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
replication, consistent with the widespread use of this cell line to
propagate different influenza viruses in vitro. Although RG-
Braz-HA infected mouse M to high levels (Fig. 1), infection of
PECM or RAW264.7M did not result in substantial increases
in the amount of replication-competent virus in culture superna-
tants at 24 h (Fig. 2A). This phenomenon was not unique to RG-
Braz-HA, as PEC M were susceptible to infection but did not
support productive replication, by a range of wild-type IAVH3N2
(Memphis/71, Pt Chalmers/73, and Beijing/89) and H1N1
(USSR/77, Brazil/78, and Sol Is/2006) strains (data not shown).
To investigate the potential ofmouseM to support growth of
seasonal IAV over time, we next infected cells with a low MOI
(0.01) in the presence of exogenous trypsin to facilitate cleavage of
the viral HA and therefore multiple cycles of virus replication.
MDCK cells supported replication of RG-Braz-HA, as titers of
infectious virus released fromMDCK cells increased progressively
between 2, 24, and 48 h postinfection (Fig. 2B). Consistent with
the data shown in Fig. 2A, mouse M did not support virus rep-
lication efficiently. A modest increase in virus titers was recorded
in RAW264.7M infectedwith RG-Braz-HAbetween 2 and 24 or
48 h, and the virus titers detected in supernatants from IAV-in-
fected PECM actually declined between 2 and 24 or 48 h postin-
fection (Fig. 2B). Together, these results confirm that following
uptake, seasonal IAV do not complete productive replication in
macrophages, representing a second level of restriction.
Mouse M, but not epithelial cells, differ in susceptibility
and responsiveness to different IAV strains. Mouse M were
largely resistant to infection with RG-PR8-HA, as detected by im-
munofluorescence for newly synthesized viral NP at 7 to 8 h
postinfection. Therefore, we hypothesized that M would sense
and respond to infection with RG-Braz-HA more efficiently than
to RG-PR8-HA. To test this, we used qRT-PCR to measure ex-
pression of host antiviral factors in mouseM and epithelial cells
after infection with RG-Braz-HA or RG-PR8-HA. PEC M and
LA-4 mouse epithelial cells in eight-well chamber slides were
mock infected or infected with 106 PFU (MOI of 5 PFU/cell) of
RG-Braz-HA or RG-PR8-HA, and at 2 h or 6 h postinfection, cells
were lysed, and RNA was extracted. The RNA was used as a tem-
plate for reverse transcriptase quantitative PCR as described in
Materials and Methods.
Mouse LA-4 epithelial cells upregulated expression of IFIT3,
IFIT1, and Eif2ak2 in response to RG-Braz-HA and RG-PR8-HA,
whereas mouse PECM responded only to RG-Braz-HA (Fig. 3,
top panels). Mda5,Mx1, and Isg20 were also strongly upregulated
in mouse M infected with RG-Braz-HA, but not RG-PR8-HA,
whereas either virus induced only modest expression of these fac-
tors in epithelial cells (Fig. 3, bottom panels). Expression of each
of the host factors tested was negligible in mock-infected mouse
M and epithelial cells. Thus, the susceptibility ofmouseM and
epithelial cells to infection correlates with their ability to sense and
respond to different IAV as assessed by induction of host antiviral
genes.Moreover, whilemouseM showmajor differences in sus-
ceptibility and responsiveness to different IAV, epithelial cells do
not.
Enhanced infection of mouseM by RG-PR8-HA following
inhibition of the viral NA. RG-Braz-HA expresses seven genes
fromPR8, implicating features of the PR8HA in the poor ability of
RG-PR8-HA to infect mouseM. Reduced HA-mediated attach-
ment to sialylated receptors and/or inefficient interactions with
appropriate entry receptors on the surface of M could limit RG-
PR8-HA infection. Alternatively, the PR8 HA may not fuse effi-
ciently withM endosomal membranes, resulting in degradation
rather than infection following virus uptake. To discriminate be-
tween these possibilities, we first examined the ability of each virus
to bind to the M cell surface. Compared to RG-Braz-HA, there
was no major difference in the ability of RG-PR8-HA to bind to
the M cell surface at 4°C (Fig. 4Ai and Aii); however, at this
temperature, the IAV NA will not be enzymatically active as it
would be in infection assays. Therefore, we infected mouse M
with RG-PR8-HA and RG-Braz-HA in the presence or absence of
the NA inhibitor zanamivir. As seen in Fig. 4Bi, low levels of M
infection by RG-PR8-HA were markedly enhanced in the pres-
ence of zanamivir, and infection was blocked by mannan and/or
ASF, consistent with CLR-mediated infection. Infection ofM by
RG-Braz-HA was slightly enhanced in the presence of zanamivir,
but this was not significant (Fig. 4Bii). Thus, mouse M are not
inherently resistant to RG-PR8-HA; instead, features of the PR8
HA (e.g., lack of glycosylation and/or avidity for SIA receptors on
M) and NA (e.g., ability to cleave SIA) limit infectious entry
under normal circumstances. Inactivation of the viral NA ap-
peared to enhance interactions between cell surface SIA and PR8
HA, promoting virus uptake and therefore more efficient infec-
tion of mouse M by RG-PR8-HA. Therefore, impaired virus
uptake into macrophages represents one level of restriction limit-
ing infection by seasonal IAV.
Viral mRNA and vRNA for each gene segment are produced
in mouse M infected with seasonal IAV. To determine at what
stage of the virus life cycle productive replication is blocked in
M, we first performed quantitative assessment of all eight gene
segments of the viral RNA (vRNA) genome, as well as their tran-
scription into mRNA. Monolayers of mouse M (PEC) and epi-
thelial cells (MDCK and LA-4 cells) were incubated with 106 PFU
MDCK LA-4 RAW  
264.7 
PEC  
MΦ  
Epithelial Macrophage 
Fo
ld
 in
cr
ea
se
 in
 v
ira
l t
itr
e 
(lo
g 
10
) 
1 
2 
3 
4 
5 MDCK 
RAW  
264.7 
PEC  
MΦ  1 
2 
3 
4 
5 
6 
7 
8 
2 24 48 
Hours post - infection 
Vi
ra
l t
itr
e  
PF
U
 / 
m
l (
lo
g 
10
)  
A B
FIG 2 IAV-infected epithelial cells, but not mouse M, support productive
viral infection. (A) Monolayers of epithelial cells (MDCK and LA-4 cells) and
mouse M (PEC and RAW264.7 cells) were incubated with an MOI of 5
PFU/cell of RG-Braz-HA for 1 h, washed extensively to remove excess virus,
and then cultured. At 2 and 24 h postinfection, cell culture supernatants were
removed and clarified by centrifugation, and titers of infectious virus were
determined by plaque assay on MDCK cells. Data represent the mean fold
increase in viral titer between 2 h and 24 hpostinfection (	 SEM), pooled from
three to five independent experiments. (B) Cell monolayers were incubated
with an MOI of 0.01 PFU/cell of RG-Braz-HA for 1 h, washed extensively to
remove excess virus, and then cultured in serum-free medium supplemented
with 1 g/ml TPCK-treated trypsin. At 2, 24, and 48 h postinfection, cell
culture supernatants were removed and clarified by centrifugation, and titers
of infectious viruswere determined by plaque assay onMDCKcells. Data show
themean virus titers from triplicate samples (	 SEM) in PFUpermilliliter and
are representative of at least two independent experiments.
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(MOI of 5 PFU/cell) of RG-Braz-HA for 1 h at 37°C and washed
extensively, and total RNAwas isolated at 2 and 6 h postinfection.
Total cellular RNA was then used as the template in a strand-
specific qRT-PCR to detect negative-sense genomic vRNA and
viral mRNA. Between 2 and 6 h postinfection, the levels of vRNA
and mRNA of all gene segments increased markedly in IAV-in-
fectedMDCK and LA-4 cells, as well as inmouseM (Fig. 5). The
2-h time point was included to account for residual virus thatmay
have entered cells but not replicated and/or remained attached to
the cell surface. Overall, there were no major defects in the syn-
thesis of any particular segments in mouse M, although vRNA/
mRNA levels of each gene segment had a tendency to be somewhat
lower in M than in epithelial cells at both 2 h and 6 h. Together,
these data indicate that vRNA andmRNA for all eight segments of
the IAV genome are synthesized in mouse M infected with sea-
sonal IAV.
Expression of IAVproteins inmouseM and epithelial cells
infected with seasonal IAV. Previous studies have reported syn-
thesis of viral HA, M, and NP in IAV-infected mouse M (7, 10,
21); however, a comprehensive analysis of IAV proteins expressed
in these cells has not been performed. Therefore, we usedWestern
blotting to detect different IAV proteins in lysates from IAV-in-
fectedM. Epithelial cells were included as positive controls, as all
viral proteins should be expressed in cells that support productive
virus replication. Briefly, monolayers of M, LA-4, or MDCK
cells were incubated with 106 PFU (MOI of 5 PFU/cell) of RG-
Braz-HA for 1 h at 37°C and washed to remove the inoculum, and
total cell lysates were prepared at 2 h (to detect input virus) and 16
h (to detect newly synthesized viral proteins) postinfection.
Mock-infected cells were included for comparison, and actin pro-
tein levels were monitored in all assays to control for any differ-
ences in loading between samples.
We did not detect significant expression of any viral protein
tested at 2 h postinfection in IAV-infected MDCK and LA-4 cells
(Fig. 6A); however, at 16 h, nonstructural proteins (NS1 andNS2)
and a number of virion-associated proteins (M1, M2, and NP)
were all expressed, consistent with de novo synthesis in virus-in-
fected cells. At 16 h postinfection, the level of each viral protein
was generally higher in MDCK cells than in LA-4 cells, consistent
with the ability of MDCK cells to support much higher levels of
productive replication (Fig. 2). In IAV-infected M, viral pro-
teins NS1/NS2 and M1/M2/NP were also detected at 16 h postin-
fection (Fig. 6A), albeit at variable levels.
Efficient transport of the IAV HA and NA to the surfaces of
host cells is important for virus morphogenesis and budding and
for release of nascent virions from infected cells after budding.
Flow cytometry confirmed upregulated expression of HA and NA
on the surfaces of IAV-infected epithelial cells andM between 2
and 8 h postinfection (Fig. 6B). The enzymatic activity of the viral
NA removes SIA from infected host cells and fromHA/NA glyco-
proteins on virions, promoting effective virus release and prevent-
ing aggregation (reviewed in reference 22). However, culture of
IAV-infected M with exogenous neuraminidase from Vibrio
cholerae (100 mU/ml) did not liberate newly synthesized infec-
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FIG 3 Mouse M, but not epithelial cells, differ in susceptibility and responsiveness to different IAV strains through the induction of host antiviral factors.
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genes Ifit1, Ifit3, and Eif2ak2 (top panels), as well as Ifih1, Mx1, and Isg20 (bottom panels) were determined by qRT-PCR using TaqMan gene expression assays
as described inMaterials andMethods. For each gene of interest, relative gene expression (	 1 standard deviation [SD]) was determined using the 2CTmethod
described in Materials and Methods, and data were pooled from three independent experiments.
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tious virus from the surfaces of IAV-infected M (data not
shown). Thus, while newly synthesized HA/NA glycoproteins are
expressed on the surfaces of IAV-infectedM, defective release of
nascent virions from the cell surface is not responsible for the
block in productive IAV replication in M.
Virus buds from the surfaces of IAV-infected epithelial cells,
but not IAV-infected M. For productive IAV replication to oc-
cur, vRNA is replicated in the nucleus before associating with NP
and the RNA polymerase subunits (PA, PB1, and PB2) such that
the assembled viral RNPs (vRNPs) exit the nucleus and traffic
along microtubules to the plasma membrane (23). Assembly of
IAV at the plasma membrane is a complex process, involving ex-
tensive interplay between multiple viral proteins before budding
virions are pinched off and released from the infected cell. There-
fore, transmission electron microscopy (TEM) was used to visu-
alize virus at the surfaces of IAV-infected M to determine
whether virions formed at the cell surfacewere unable to complete
the budding process. In these studies, monolayers of PEC M or
MDCK epithelial cells were infectedwith 106 PFU (MOI of 5 PFU/
cell) of RG-PR8-HA and washed, and at 16 h postinfection, the
cells were fixed and examined by TEM as described in Materials
andMethods. As seen in Fig. 7, virus buddingwas readily observed
from the surfaces of epithelial cells, consistent with release of in-
fectious virus and productive IAV infection in these cells. How-
ever, we did not observe any evidence of virus budding at the
plasmamembrane of IAV-infectedM in any sections examined.
DISCUSSION
Data presented herein demonstrate that interactions between sea-
sonal IAV and mouse M can be restricted at two levels. The first
restriction, at the level of virus attachment and entry, relates to the
poor capacity of particular IAV to recognize appropriate attach-
ment factors (SIA) and entry receptors (CLR) on the surfaces of
M. RG-PR8-HA infectedmouseM poorly, resulting in limited
synthesis of viral NP and little “sensing” of viral infection, as im-
plied by the modest induction of antiviral host genes. This is not
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FIG 4 Both RG-PR8-HA and RG-Braz-HA bind to epithelial cells and mouse M; however, inhibition of the viral NA results in enhanced infection of mouse
M by RG-PR8-HA. (A) Epithelial cells (MDCK) and mouse M (RAW264.7) were incubated with 10 g/ml of purified RG-PR8-HA and RG-Braz-HA or no
virus (mock infected) for 30 min on ice. After the cells were washed, virus bound to the cell surface was detected using anti-NA polyclonal rabbit sera in
conjunctionwith goat anti-rabbit Ig–FITC conjugate, followed by flow cytometry. (i) Representative histograms show binding of RG-PR8-HA andRG-Braz-HA
to epithelial cells andM. Staining of mock-infected cells are displayed as solid gray histograms. (ii) Data are expressed as the mean fold change (	 SEM) in the
geometric means of RG-PR8-HA or RG-Braz-HA bound to the cell surface relative to the geometric mean of the no-virus (mock) control. The data show pooled
triplicate samples from three independent experiments. There was no significant difference (n.s) in the level of RG-PR8-HA compared with RG-Braz-HA bound
to epithelial cells (P
 0.16) orM (P
 0.45) (two-tailed Student’s t test). (B)Monolayers ofmouseM (PEC)were infectedwith 107 PFU (MOIof 50 PFU/cell)
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were also treated with 10 mg/ml mannan or 5 mg/ml asialofetuin (ASF) or mock treated to block CLR-virus interactions. Monolayers were then washed and
incubated for a further 6 to 7 h in the presence or absence of zanamivir with either mannan or ASF or mock treatment. Cells were fixed and stained by
immunofluorescence to detect expression of newly synthesized viral NP. Data represent themean percent infection (	 SEM) fromno less than four independent
fields per chamber and are representative of two independent experiments. Values that were significantly different (P 0.05 by one-way ANOVA with Tukey’s
posthoc analysis) are indicated by bar and asterisk. Values that were not significantly different (P 0.05) are indicated by a bar and n.s.
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likely to reflect differences in stability and/or degradation ofNP or
other viral proteins, since RG-Braz-HA and RG-PR8-HA differ
only in the HA that is expressed. While PR8 HA binds preferen-
tially to 2,3-linked SIA and mouse M express 2,6-linked SIA,
resialylation of M to express 2,3-linked SIA restored suscepti-
bility to CLR-mediated infection by PR8 (24). Herein, RG-
PR8-HA infected mouse M to high levels in the presence of the
neuraminidase inhibitor zanamivir, and infection was blocked by
multivalent ligands of CLR. In both instances, enhanced binding
to cell surface SIA promoted interactions between the poorly gly-
cosylated PR8 HA and CLR on M, resulting in infectious entry
and detection of viral NP 6 to 8 h postinfection. These data imply
no major defects in the ability of the PR8 HA to fuse with endo-
somal membranes or commence viral replication but instead im-
ply that attachment and entry into M are not efficient under
normal circumstances.
The second level of restriction refers to the inability of seasonal
IAV to complete productive replication in M. Thus, RG-
Braz-HA IAV infectedmouseM to high levels, but no infectious
progeny were released. Chan et al. reported upregulation of M
mRNA and protein during productive replication of seasonal IAV
in mouse bone marrow-derived M (21), and synthesis of HA
and NP proteins has been reported during nonproductive repli-
cation inmouseM (7, 10). To our knowledge, the current study
is the first to examine the synthesis of viral mRNA and vRNA
corresponding to all segments of the IAV genome during nonpro-
ductive replication of IAV in M. Our data clearly demonstrate
that new copies of vRNA and viral mRNA corresponding to each
genome segment were synthesized in IAV-infected mouse M.
Moreover, we demonstrate synthesis of nonstructural proteins
(NS1 and NS2) and virion-associated proteins (NP, HA, NA, M1,
andM2), with abundant expression ofHA andNAon the surfaces
of IAV-infected M. While our studies detected the majority of
viral proteins, they do not shed light on whether the proteins are
present in sufficient quantities and ratios or provide information
regarding appropriate protein stability and/or localization to fa-
cilitate virus assembly. For example, abortive replication of IAV in
L929 cells was associated with low levels of M1 protein (25),
whereas overproduction of M2 protein was associated with non-
productive infection in Vero cells (26). Furthermore, viral pro-
teins are subject to various posttranslational modifications (re-
viewed in references 27 to 29), including glycosylation (HA/NA),
palmitoylation (HA and M2), SUMOylation (i.e., conjugation
with the small ubiquitin-like modifier; M1, NS1, NP, PB1, and
NS2), and phosphorylation (M1,NP,NS1, PB1, and PB1-F2), and
modulation of these processes in IAV-infected M might also
affect stability and/or function of particular viral proteins.
While not examined in our study, defective synthesis and/or
degradation of one or more of the viral polymerase proteins (PA,
PB1, and PB2) might also limit IAV replication in M at a late
stage in the virus life cycle. For example, specific mutations in the
viral PA were shown to abrogate IAV replication in epithelial cells
despite expression of PA RNA products (30), leading the authors
to propose that PA may be influencing virus assembly and/or re-
lease by an unknownmechanism(s). Given that polymerase trim-
ers are bound to each vRNA segment in the virion core, perturba-
tions of PA, PB1, or PB2 may also disrupt the structural integrity
of the core. Note that PB1-F2 expression was not examined and
while deletionmutants indicate that this viral protein is not essen-
tial for IAV replication in cell culture andmice (31, 32), we cannot
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rule out the possibility that altered PB1-F2 expression might also
contribute to abortive IAV replication in M.
IAV assembly and budding are complex, multistep processes
that occur in lipid raft domains on the apical surfaces of infected
cells (reviewed in reference 33). Clustering of HA and NA in lipid
rafts has been implicated in inducing deformation of the plasma
membrane and the initiation of virus budding. Flow cytometry
demonstrated that HA and NA were clearly transported to the
surfaces of IAV-infected M, yet TEM revealed a complete ab-
sence ofmembrane-associated viral particles. This contrasts abor-
tive IAV infection in HeLa cells where virus particles assembled,
but were not released, from the plasmamembrane (34). Rather, it
has similarities with abortive IAV replication in L929 cells, where
both HA and NA were synthesized and transported to the plasma
membrane, but deficientM protein synthesis resulted in defective
virus assembly (25). Thus, while we have not defined the precise
block in productive infection of seasonal IAV in mouse M, our
data support the concept of a block in virus assembly prior to
budding from the surfaces of infected cells.
Recent studies have identified a number of host antiviral re-
striction factors that limit intracellular replication of a range of
viruses, including IAV. As interferon-stimulated genes (ISGs),
such as human myxovirus resistance gene A (MxA), block multi-
ple steps in viral RNA replication (35, 36), they are unlikely to be
the major factors regulating nonproductive replication in M, as
vRNPs enter the nucleus efficiently and promote transcription
and replication of viral genes. Similarly, IFN-inducible transmem-
brane 3 (IFITM-3) limits replication of IAV and other enveloped
viruses in epithelial cells (reviewed in reference 37) by preventing
cytosolic entry (38), and IAV replication inM is blocked later in
the virus life cycle. In epithelial cells, tetherin (also named BST-2)
and viperin have been implicated in limiting release of nascent
virions from the plasma membrane (39–41); however, our data
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FIG 7 Virus budding from RG-Brazil-HA-infected epithelial cells but not
mouse M. Monolayers of mouse M (PEC) and epithelial cells (MDCK
cells) were incubated with an MOI of 5 PFU/cell of RG-Braz-HA for 1 h at
37°C, washed to remove excess virus, and cultured. At 16 h postinfection, cells
were fixed and examined by TEM as described in Materials and Methods.
Virions and densely stained particles budding from the plasma membrane of
epithelial cells (indicated by black arrows), but not from mouse M, can be
observed.
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indicate that nonproductive replication in M is restricted prior
to the development of virus buds. Thus, while studies have impli-
cated particular ISGs in limiting IAV infection of epithelial cells,
the factors that block productive IAV replication in M are not
known.
Mda5, Mx1, and Isg20 were strongly upregulated in IAV-in-
fected M but not epithelial cells, suggesting cell-specific differ-
ences in the induction of these antiviral host factors. Similarly,
transcripts for NLRP3, together with its adaptor protein pyrin
domain (PYD)- and caspase activation and recruitment domain
(CARD)-containing protein (PYCARD) were highly expressed in
M, but not in AEC, from naive mice, and IAV infection induced
differential regulation of these genes in each cell type (42). Vi-
perin/ M and DC, but not neurons or fibroblasts, showed
enhanced permissivity toWestNile virus (WNV) replication (43),
consistentwith the notion that the antiviral roles of particular host
factors can be cell specific.Moreover, identification of ISGs differ-
entially regulated in WNV-permissive and WNV-nonpermissive
neurons allowed for ectopic expression of candidate ISGs in per-
missive neurons to identify three genes that conferred antiviral
activity againstWNV, but not against unrelated alphaviruses (44).
A broader understanding of the different ISGs and host genes
induced in response to seasonal IAV inM and epithelial cells will
be an important step toward identifying specific factors that block
IAV replication in M, presumably by regulating the synthesis
and/or stability of specific viral proteins and/or by interferingwith
the process of virus assembly.
For the purposes of this study, we have used genetically defined
IAV representative of seasonal IAV and which, like seasonal IAV,
do not replicate productively in mouse M. A recent study re-
ported that murine M-supported productive replication by
HPAI H5N1 and reassortant viruses expressing individual H5N1
genes in the context of seasonal IAV demonstrated that overcom-
ing the “block” in productive replication mapped exclusively to
the HA gene of HPAI H5N1 (11). Currently, the features of the
HPAI H5 HA that allow these viruses to replicate in mouse M
have not been elucidated; however, these findings suggest that
M express all appropriate cellular factors andmachinery to sup-
port IAV growth. Moreover, they imply that HPAI H5N1 evade
cellular restriction factors that block the replication of seasonal
IAV in M. Ongoing experiments in the laboratory aim to iden-
tify the specific host cell factors that restrict replication of seasonal
IAV in M.
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